Plasma filtration (PF) effectively removes circulating pegylated liposomal doxorubicin (pld) and modifies chemotherapy-related toxicity in metastatic ovarian cancer
Statement of the Problem: Pegylated liposomal doxorubicin (PLD), a formulation of doxorubicin hydrochloride encapsulated in polyethyleneglycol-coated liposomes, has proved its efficacy in the treatment of ovarian cancer…

